Index
S&P 500
P/E
21.96
EPS (ttm)
3.31
Insider Own
1.48%
Shs Outstand
114.42M
Perf Week
5.38%
Market Cap
8.28B
Forward P/E
12.31
EPS next Y
5.91
Insider Trans
-5.38%
Shs Float
96.61M
Perf Month
-7.77%
Enterprise Value
13.45B
PEG
1.32
EPS next Q
1.23
Inst Own
94.11%
Perf Quarter
-5.83%
Income
395.00M
P/S
0.62
EPS this Y
7.57%
Inst Trans
-6.24%
Perf Half Y
-0.87%
Sales
13.38B
P/B
2.55
EPS next Y
10.50%
ROA
3.63%
Perf YTD
-3.80%
Book/sh
28.54
P/C
60.02
EPS next 5Y
9.34%
ROE
12.01%
52W High
89.29 -18.57%
Perf Year
0.91%
Cash/sh
1.21
P/FCF
18.61
EPS past 3/5Y
-5.75% 3.12%
ROIC
6.75%
52W Low
61.94 17.37%
Perf 3Y
-5.02%
Dividend Est.
-
EV/EBITDA
12.16
Sales past 3/5Y
1.40% 5.43%
Gross Margin
29.19%
Volatility
3.14% 3.16%
Perf 5Y
-8.37%
Dividend TTM
-
EV/Sales
1.00
EPS Y/Y TTM
2.92%
Oper. Margin
5.88%
ATR (14)
2.28
Perf 10Y
8.51%
Dividend Ex-Date
-
Quick Ratio
0.75
Sales Y/Y TTM
5.64%
Profit Margin
2.95%
RSI (14)
46.93
Dividend Gr. 3/5Y
- -
Current Ratio
1.36
EPS Q/Q
4.63%
SMA20
-1.37%
Beta
0.82
Payout
0.00%
Debt/Eq
1.15
Sales Q/Q
6.31%
SMA50
-2.44%
Rel Volume
0.46
Prev Close
72.72
Employees
25000
LT Debt/Eq
0.79
SMA200
0.09%
Avg Volume
1.46M
Price
72.71
IPO
Nov 03, 1995
Option/Short
Yes / Yes
Trades
Volume
298,276
Change
-0.02%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-16-26 Initiated
BTIG Research
Neutral
Apr-15-26 Initiated
Citigroup
Buy
$100
Feb-23-26 Upgrade
Robert W. Baird
Neutral → Outperform
$100
Dec-09-25 Initiated
Barclays
Overweight
$86
Aug-26-25 Upgrade
Evercore ISI
In-line → Outperform
$83
Jul-25-25 Downgrade
Stifel
Buy → Hold
$75
Jul-14-25 Downgrade
Robert W. Baird
Outperform → Neutral
$72
Feb-14-25 Initiated
Wells Fargo
Equal Weight
$80
Jan-06-25 Upgrade
BofA Securities
Underperform → Buy
$69 → $84
Dec-04-24 Initiated
Mizuho
Neutral
$75
Jul-22-24 Upgrade
Robert W. Baird
Neutral → Outperform
$81 → $92
Feb-26-24 Initiated
Leerink Partners
Market Perform
$78
Dec-12-23 Upgrade
JP Morgan
Neutral → Overweight
$71 → $82
Nov-10-23 Upgrade
Stifel
Hold → Buy
$70
Aug-08-22 Upgrade
UBS
Sell → Neutral
$80
Jul-21-22 Downgrade
Goldman
Buy → Neutral
$93 → $85
Jun-14-22 Downgrade
Robert W. Baird
Outperform → Neutral
$103 → $88
May-13-22 Resumed
Credit Suisse
Outperform
$100
Jan-31-22 Initiated
Morgan Stanley
Underweight
$67
Jan-07-22 Upgrade
Credit Suisse
Neutral → Outperform
$78 → $90
Show Previous Ratings
May-14-26 06:30AM
May-05-26 12:51PM
10:55AM
06:06AM
06:00AM
06:30AM
Loading…
May-04-26 06:30AM
Apr-30-26 06:30AM
Apr-28-26 10:04AM
Apr-21-26 06:30AM
Apr-20-26 12:12PM
Apr-16-26 09:47AM
Apr-15-26 09:47AM
Apr-08-26 07:00AM
Apr-07-26 03:08PM
Mar-30-26 03:22AM
06:30AM
Loading…
Mar-18-26 06:30AM
Mar-10-26 06:30AM
Mar-05-26 09:40AM
Mar-03-26 06:30AM
Mar-02-26 09:45AM
Feb-24-26 03:10PM
02:03PM
01:55PM
12:32PM
11:47AM
11:10AM
09:59AM
09:30AM
08:46AM
07:54AM
07:35AM
Loading…
07:35AM
06:17AM
(Associated Press Finance)
06:00AM
Feb-23-26 09:32AM
Feb-22-26 10:09PM
Feb-19-26 10:00AM
06:30AM
Feb-17-26 10:00AM
09:19AM
06:30AM
Feb-16-26 10:39AM
Feb-06-26 06:30AM
Jan-22-26 06:30AM
Jan-20-26 09:47AM
Jan-15-26 10:00AM
Jan-14-26 11:06PM
01:27PM
Jan-13-26 09:40AM
Jan-12-26 11:15AM
09:57AM
07:00AM
Jan-06-26 11:40AM
Jan-05-26 12:37AM
Dec-29-25 06:30AM
Dec-26-25 09:50AM
Dec-23-25 04:05PM
Dec-18-25 07:54AM
Dec-09-25 04:00PM
02:37PM
Dec-04-25 11:30AM
Dec-03-25 10:31PM
Dec-02-25 08:25AM
Dec-01-25 04:34PM
07:52AM
Nov-25-25 06:30AM
Nov-13-25 09:40AM
06:30AM
Nov-12-25 07:00AM
Nov-11-25 08:26AM
Nov-07-25 09:50AM
Nov-06-25 10:21PM
09:45AM
08:00AM
(Investor's Business Daily)
Nov-04-25 04:00PM
09:30AM
08:54AM
07:10AM
06:36AM
06:10AM
(Associated Press Finance)
06:00AM
Nov-03-25 06:30AM
Nov-02-25 10:13PM
Oct-29-25 10:00AM
Oct-28-25 10:00AM
Oct-23-25 08:07AM
Oct-22-25 06:30AM
Oct-21-25 07:28AM
06:30AM
Oct-15-25 10:30AM
Oct-08-25 12:02AM
Sep-25-25 01:07PM
07:22AM
Sep-17-25 01:15PM
Sep-16-25 09:32AM
Sep-11-25 08:31AM
Sep-09-25 05:10PM
10:18AM
Aug-28-25 11:31PM
Aug-22-25 06:30AM
Aug-21-25 11:39AM
Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, laboratory, small and large equipment repair services, branded and generic pharmaceuticals, vaccines, surgical, diagnostic tests, infection-control products, and vitamins. The Technology and Value-Added Services segment offers financial on a non-recourse basis, network, and hardware services. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.
Senior VP & CFO Mr. Ronald N. South
Executive VP & COO Mr. Michael Saul Ettinger
Executive VP & Chief Strategic Officer Mr. Mark E. Mlotek
Chief Executive Officer of Global Distribution & Technology Mr. Andrea Albertini
CEO & Director Mr. Frederick M. Lowery
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
DANIEL WILLIAM K Director May 11 '26 Buy 69.19 10,000 691,900 20,000 May 12 04:15 PM Popeck Thomas C CEO, Henry Schein Products Mar 19 '26 Sale 72.79 1,355 98,630 86,182 Mar 20 04:07 PM Popeck Thomas C Officer Mar 19 '26 Proposed Sale 72.79 1,355 98,630 Mar 19 12:30 PM KUEHN KURT P Director Mar 10 '26 Sale 78.96 2,844 224,565 15,420 Mar 11 04:08 PM KUEHN KURT P Director Mar 10 '26 Proposed Sale 78.96 2,844 224,565 Mar 10 01:42 PM MLOTEK MARK E EVP, Chief Strategic Officer Mar 04 '26 Sale 80.80 5,925 478,740 80,554 Mar 06 06:08 PM LASKAWY PHILIP A Director Mar 05 '26 Sale 80.36 2,844 228,544 21,961 Mar 06 05:08 PM LASKAWY PHILIP A Director Mar 05 '26 Proposed Sale 80.36 2,844 228,544 Mar 05 12:40 PM MLOTEK MARK E Officer Mar 04 '26 Proposed Sale 80.80 5,925 478,739 Mar 04 04:28 PM BERGMAN STANLEY M Chairman, CEO Mar 02 '26 Sale 81.31 43,812 3,562,354 383,803 Mar 03 08:18 AM Stanley M. Bergman CEO, Chairman Mar 02 '26 Proposed Sale 82.39 43,812 3,609,671 Mar 02 06:31 PM BERGMAN STANLEY M Chairman, CEO Feb 26 '26 Sale 81.01 38,346 3,106,591 427,615 Feb 27 04:31 PM BERGMAN STANLEY M Chairman, CEO Feb 27 '26 Sale 81.20 10,785 875,742 309,092 Feb 27 04:31 PM Stanley M. Bergman CEO, Chairman Feb 27 '26 Proposed Sale 81.47 10,785 878,654 Feb 27 04:22 PM Stanley M. Bergman Officer Feb 26 '26 Proposed Sale 81.91 43,046 3,525,898 Feb 26 04:25 PM Siegel Walter Officer Nov 17 '25 Proposed Sale 71.30 4,176 297,749 Nov 17 10:29 AM DANIEL WILLIAM K Director Aug 07 '25 Buy 67.08 10,000 670,800 10,000 Aug 11 04:26 PM